NCT01159223 - Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA) | Biotech Hunter

Enrollment

559

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

June 30, 2015

Conditions

HIV Infections

Interventions

DRUG

ATV/r

All participants will be randomized to take ATV/r 200 mg/100 mg OD or ATV/r 300/100 mg OD. NRTIs background regimens will remain unchanged if possible. NRTIs background may include zidovudine/lamivudine, zidovudine plus ddI, ddI plus lamivudine, tenofovir plus lamivudine, tenofovir/emtricitabine, zidovudine plus tenofovir. NRTI backbone could be switched or modified due to toxicity or intolerance

Trial Locations (10)

10330

HIV-NAT, Thai Red Cross AIDS Research Centre, Bangkok

11000

Bamrasnaradura Infectious Diseases Institute, Nonthaburi

Unknown

Chiang Rai Regional Hospital, Chiang Rai

ChonBuri Hospital, Chon Buri

Khon Kaen University, Khon Kaen

Sanpathong Hospital, Sanpathong

BMA Medical College and Vajira Hospital, Bangkok

Ramathibodi Hospital, Bangkok

Taksin hospital, Bangkok

Khon Kaen Hospital, Khon Kaen